Biotechnology
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)
HYDERABAD, India, Aug. 26, 2021 /PRNewswire/ -- Sai Life Sciences, a leading
globalContract Research, Development & Manufacturing Organization
XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos
BEIJING, Aug. 25, 2021 /PRNewswire/ -- Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently issued an honorary certificate to Beijing Applied Biological Technologies (XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to supportVientiane's efforts at epidemic ...
Innovent Announced 2021 Interim Results with Total Revenue of RMB 1,941.8 Million and Accelerated Global R&D Footprint
SAN FRANCISCO and SUZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
Angel Yeast Announces Acquisition of Bio Sunkeen's Yeast Relevant Assets
YICHANG, China, Aug. 25, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast
")(en.angelyeast.com
Global Cord Blood Corporation to Report First Quarter Fiscal 2022 Financial Results
HONG KONG, Aug. 25, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...
Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients
DURHAM, N.C. and BEIJING, Aug. 25, 2021 /PRNewswire/ -- Brii Biosciences
Advanced Sterilization Products Announces Launch in Asia Pacific of The Fastest Biological Indicator For Hydrogen Peroxide Sterilization
SINGAPORE, Aug. 25, 2021 /PRNewswire/ -- Advanced Sterilization Products (ASP)
announced today that the STERRAD VELOCITY™ Biological Indicator (BI)/Process
Challenge Device (PCD) 15-minute time to result will be commercially available
in theAsia Pacific region# from 25 August 2021.
Athos Therapeutics Announces Research Collaboration with Cleveland Clinic to Advance Precision Medicine in Inflammatory Bowel Disease
LOS ANGELES, Aug. 25, 2021 /PRNewswire/ -- Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with immune-mediated diseases, announced today a comprehensive Master Research Agreement for a coll...
ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics
Highlights: * AdAlta and Carina Biotech enter a collaboration agreement to develop i-body enabled CAR-T cancer immunotherapies against up to five solid tumour antigen targets * Combining Carina's advanced CAR-T platform technologies with AdAlta's i–body targeting capability aims to create un...
Ascentage Pharma Announces 2021 Interim Results Highlighting the Potential of Its Core Drug Candidates and Major Breakthroughs in Strategic Collaborations
SUZHOU, China, and ROCKVILLE, Md., Aug. 24, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its 2021 interim results and released an updat...
China Medical System Holdings Limited 2021 Interim Results Announcement
Business Performance Reached Record High Turnover Increased by 23.6% to RMB3,843.0 Million Profit Increased by 25.5% to RMB1,631.6 Million Industrial Investment Enables Innovation Incubation New Businesses Boost Future Development Financial Highlights For the 6 months ended 30 June 2021 (RMB ...
Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China
SHANGHAI and HONG KONG, Aug. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...
Genscript Biotech Reports 2021 Interim Financial Results
Strong Momentum across All Business Segments, particularly in Gene & Cell Therapy CDMO Continue to accelerate R&D investment to capture Future Growth * Revenue of the Group for the six months ended June 30, 2021 was approximately US$229.6 million, representing an increase of 38.0% as compared...
Himalaya Therapeutics Announces Registration of its Office in Shanghai
SHANGHAI and SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China, of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, wh...
Excelra launches a re-envisioned version of GOSTAR, its structure-activity relationship application, with an innovative set of new features to accelerate the drug discovery cycle
HYDERABAD, India, Aug. 23, 2021 /PRNewswire/ -- Today, Excelra
WuXi Biologics Reports Strong 2021 Interim Results
* Revenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million * Gross Profit Grows by 191.7% Y-o-Y to RMB2,296.8 Million * Adjusted Net Profit Attributable to Owners of the Company Increases by 163.0% Y-o-Y toRMB1,768.7 Million * Gross and Net Profit Margins Reach 52.1% and 42.7%, Respectively ...
Study Confirms Viraleze Antiviral Nasal Spray Provides Protection Against SARS-CoV-2 in Challenge Model
MELBOURNE, Australia, Aug. 23, 2021 /PRNewswire/ -- Melbourne biotech company Starpharma has announced the publication of new data demonstrating the capability of its Viraleze antiviral nasal spray to protect against SARS-CoV-2 in an animal challenge model of SARS-CoV-2 infection[1]. Viraleze adm...
RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn's
U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035 Opaganib's 475-patient global Phase 2/3 study in severe COVID-19 approaching completion with upcoming top-line results Opaganib also undergoing two oncology Phase 2 U.S. studies a...
Codex Beauty Labs is the Official Skincare of SupermodelMe Revolution SMM
SAN JOSE, Calif., Aug. 23, 2021 /PRNewswire/ -- Codex Beauty Labs, a plant-powered biotech skincare brand, is proud to announce that they are the Official Skincare for SMM Season 6 SupermodelMe Revolution. "We are honored to be the Official Skincare for the show! Codex Beauty Labs is revolutioni...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Multiple achievements made in China-Hungary BRI conference
[Picked up by 310 media titles]
2024-05-03 06:59Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 281 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39